Literature DB >> 17325254

Pulmonary vascular disease in adults with congenital heart disease.

Gerhard-Paul Diller1, Michael A Gatzoulis.   

Abstract

Pulmonary arterial hypertension of variable degree is commonly associated with adult congenital heart disease. Depending on size and location of the underlying cardiac defect as well as on repair status, pulmonary arterial hypertension may present with or without reversed shunting and associated cyanosis (ie, Eisenmenger syndrome). We review available data on etiology, clinical presentation, prognosis, and management strategies of pulmonary arterial hypertension in adult patients with congenital heart disease. In addition, we discuss the numerous complications associated with Eisenmenger syndrome, representing a multisystem disorder. Finally, we present general management strategies and emerging disease-targeting therapies.

Entities:  

Mesh:

Year:  2007        PMID: 17325254     DOI: 10.1161/CIRCULATIONAHA.105.592386

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  59 in total

Review 1.  Epidemiology of pulmonary arterial hypertension.

Authors:  Xin Jiang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

2.  Pulmonary hypertension due to presence of isolated partial anomalous pulmonary venous connection: A case report.

Authors:  Tarun Kumar; Soumya Patra; Rangaraj Ramalingam; Navin Agrawal; Ashish Agarwal; Cholenahalli Nanjappa Manjunath
Journal:  J Cardiovasc Dis Res       Date:  2014-02-18

Review 3.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

Review 4.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

5.  The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension.

Authors:  Zhi-wei Huang; Zhi-xin Fan; Jian-tao Sun; Wei-min Li; Yan-qing Gao; Yi-hua Quan; Ya-ming Geng; Yan-yan Niu; Bing-xiang Wu
Journal:  Heart Vessels       Date:  2011-09-17       Impact factor: 2.037

Review 6.  Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.

Authors:  Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

7.  Brain diffusion changes in Eisenmenger syndrome.

Authors:  Ferit Dogan; Dilek Sen Dokumaci; Ali Yildirim; Erol Bozdogan; Fatima N Boyaci; Bulent Koca; Ekrem Karakas
Journal:  Br J Radiol       Date:  2016-10-21       Impact factor: 3.039

8.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

9.  Clinical practice: pulmonary hypertension in children.

Authors:  Daniel De Wolf
Journal:  Eur J Pediatr       Date:  2009-01-16       Impact factor: 3.183

10.  Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease.

Authors:  Kanrawee Sungprem; Apichai Khongphatthanayothin; Patchara Kiettisanpipop; Pairoj Chotivitayatarakorn; Yong Poovorawan; Pornthep Lertsapcharoen
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.